Media Summary: Session Chairs: Sanam Loghavi and Marie Sebert WHO 2022 Ulrich Germing ICC 2022 Robert P. Hasserjian Harmonized ... Session Chairs: Amy E. DeZern and Saskia Langemeijer EPO and Lenalidomide in In this podcast episode, leading experts share key updates in the management of myelodysplastic syndromes (

Mds Classifications Webinar 2025 - Detailed Analysis & Overview

Session Chairs: Sanam Loghavi and Marie Sebert WHO 2022 Ulrich Germing ICC 2022 Robert P. Hasserjian Harmonized ... Session Chairs: Amy E. DeZern and Saskia Langemeijer EPO and Lenalidomide in In this podcast episode, leading experts share key updates in the management of myelodysplastic syndromes ( Session Chairs: Shahram Kordasti and Arjan van de Loosdrecht Niche/immunology/taxonomy in Session Chairs: Joop Jansen Confirmed and Austin Kulasekararaj Molecular pathogenesis of ... which helps us clinching the diagnosis of

Session Chairs: Saskia Langemeijer and Arjan A. Van de Loosdrecht What is to be Expected of Emerging New Therapies in Session Chairs: Robert P. Hasserjian and Aristoteles Giagounidis Cytology and Immunohistochemistry Sanam Loghavi Flow ... Session Chairs: Maria D. Diez-Campelo and Guillermo Garcia-Manero Imetelstat Valeria Santini HMA in Low Risk Session Chairs: Arjan Van de Loosdrecht and Saskia Langemeijer Welcome Arjan Van de Loosdrecht and Saskia Langemeijer ...

Photo Gallery

MDS Classifications Webinar 2025
MDS 2025: Plenary Session 5: MDS classification in 2025
Automated tool for MDS classification using the WHO & ICC classification systems
Updates on MDS Classifications
Advances made in MDS classification and risk stratification: ongoing work & future perspectives
MDS 2025: Plenary Session 6: Treatment Low Risk MDS (Part 1)
Top updates in MDS from ASH 2025: key trial updates and debated topics
MDS 2025: Plenary Session 2: Immunology and Microenvironment in MDS
MDS 2025: Plenary Session 1: Molecular Pathogenesis of MDS
Hematology Update in MDS
MDS 2025: Keynote Lecture
Diagnosing MDS
Sponsored
Sponsored
View Detailed Profile
MDS Classifications Webinar 2025

MDS Classifications Webinar 2025

Presented by Dr. Yee,

MDS 2025: Plenary Session 5: MDS classification in 2025

MDS 2025: Plenary Session 5: MDS classification in 2025

Session Chairs: Sanam Loghavi and Marie Sebert WHO 2022 Ulrich Germing ICC 2022 Robert P. Hasserjian Harmonized ...

Sponsored
Automated tool for MDS classification using the WHO & ICC classification systems

Automated tool for MDS classification using the WHO & ICC classification systems

Rashmi Kanagal-Shamanna,

Updates on MDS Classifications

Updates on MDS Classifications

Did you know that not every

Advances made in MDS classification and risk stratification: ongoing work & future perspectives

Advances made in MDS classification and risk stratification: ongoing work & future perspectives

In this discussion, Uma Borate,

Sponsored
MDS 2025: Plenary Session 6: Treatment Low Risk MDS (Part 1)

MDS 2025: Plenary Session 6: Treatment Low Risk MDS (Part 1)

Session Chairs: Amy E. DeZern and Saskia Langemeijer EPO and Lenalidomide in

Top updates in MDS from ASH 2025: key trial updates and debated topics

Top updates in MDS from ASH 2025: key trial updates and debated topics

In this podcast episode, leading experts share key updates in the management of myelodysplastic syndromes (

MDS 2025: Plenary Session 2: Immunology and Microenvironment in MDS

MDS 2025: Plenary Session 2: Immunology and Microenvironment in MDS

Session Chairs: Shahram Kordasti and Arjan van de Loosdrecht Niche/immunology/taxonomy in

MDS 2025: Plenary Session 1: Molecular Pathogenesis of MDS

MDS 2025: Plenary Session 1: Molecular Pathogenesis of MDS

Session Chairs: Joop Jansen Confirmed and Austin Kulasekararaj Molecular pathogenesis of

Hematology Update in MDS

Hematology Update in MDS

... which helps us clinching the diagnosis of

MDS 2025: Keynote Lecture

MDS 2025: Keynote Lecture

Session Chairs: Saskia Langemeijer and Arjan A. Van de Loosdrecht What is to be Expected of Emerging New Therapies in

Diagnosing MDS

Diagnosing MDS

Join us as we discuss how

Acute Myeloid Leukemia: Treatment Advances

Acute Myeloid Leukemia: Treatment Advances

The New & Emerging Treatments

Stem Cell Transplants and Cell Therapies for MDS

Stem Cell Transplants and Cell Therapies for MDS

This

MDS 2025: Plenary Session 4: Integrated MDS diagnostics in 2025

MDS 2025: Plenary Session 4: Integrated MDS diagnostics in 2025

Session Chairs: Robert P. Hasserjian and Aristoteles Giagounidis Cytology and Immunohistochemistry Sanam Loghavi Flow ...

Disease-Related Fatigue

Disease-Related Fatigue

This

MDS 2025: Plenary Session 7: Treatment Low Risk MDS (Part 2)

MDS 2025: Plenary Session 7: Treatment Low Risk MDS (Part 2)

Session Chairs: Maria D. Diez-Campelo and Guillermo Garcia-Manero Imetelstat Valeria Santini HMA in Low Risk

MDS 2025: Opening Ceremony & Keynote Lecture

MDS 2025: Opening Ceremony & Keynote Lecture

Session Chairs: Arjan Van de Loosdrecht and Saskia Langemeijer Welcome Arjan Van de Loosdrecht and Saskia Langemeijer ...